• FDA DYMISTA NDA 202236 approval records — 22 FDA documents, 848 pages
1 1

FDA 510(k) K152437, BiowaveHOME Neuromodulation Pain Therapy Device, by Biowave Corporation

FDA 510(k) K152437, BiowaveHOME Neuromodulation Pain Therapy Device, by Biowave Corporation

$89.00 USD
$89.00 USD
Sale Sold out
510(K) Number: K152437
Device Name: BiowaveHOME Neuromodulation Pain Therapy Device
Manufacturer: Biowave Corporation
Device Classification Name: stimulator, nerve, transcutaneous, for pain relief
Regulation Number: 882.5890
Classification Product Code: GZJ
Date Received: 08/27/2015
Decision Date: 09/25/2015
Regulation Medical Specialty: Neurology
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome